Trade-Ideas LLC identified

OraSure Technologies

(

OSUR

) as a strong and under the radar candidate. In addition to specific proprietary factors, Trade-Ideas identified OraSure Technologies as such a stock due to the following factors:

  • OSUR has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $3.6 million.
  • OSUR has traded 55.91040000000000276259015663526952266693115234375 options contracts today.
  • OSUR is making at least a new 3-day high.
  • OSUR has a PE ratio of 47.
  • OSUR is mentioned 1.87 times per day on StockTwits.
  • OSUR has not yet been mentioned on StockTwits today.
  • OSUR is currently in the upper 20% of its 1-year range.
  • OSUR is in the upper 35% of its 20-day range.
  • OSUR is in the upper 45% of its 5-day range.
  • OSUR is currently trading above yesterday's high.

'Strong and Under the Radar' stocks tend to be worthwhile stocks to watch for a variety of factors including historical back testing and price action. Market technicians refer to such stocks as being in an accumulation phase before a mark-up and peak. Traders and hedge funds have frequently found that these types of stocks continue to build a solid price base and then ultimately spike higher and peak when others 'discover' how good the stock is performing. By leveraging the social discovery aspect of StockTwits we are highlighting stocks that don't currently receive much attention from retail investors, but we suspect may soon garner more attention.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in OSUR with the Ticky from Trade-Ideas. See the FREE profile for OSUR NOW at Trade-Ideas

More details on OSUR:

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. OSUR has a PE ratio of 47. Currently there are 2 analysts that rate OraSure Technologies a buy, no analysts rate it a sell, and 1 rates it a hold.

The average volume for OraSure Technologies has been 596,300 shares per day over the past 30 days. OraSure has a market cap of $373.3 million and is part of the health care sector and health services industry. The stock has a beta of 1.30 and a short float of 4.3% with 4.08 days to cover. Shares are up 2.6% year-to-date as of the close of trading on Wednesday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates OraSure Technologies as a

hold

. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income and revenue growth. However, as a counter to these strengths, we find that the stock has had a decline in price during the past year.

Highlights from the ratings report include:

  • ORASURE TECHNOLOGIES INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past year. We feel that this trend should continue. This trend suggests that the performance of the business is improving. During the past fiscal year, ORASURE TECHNOLOGIES INC turned its bottom line around by earning $0.14 versus -$0.09 in the prior year. This year, the market expects an improvement in earnings ($0.16 versus $0.14).
  • The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Health Care Equipment & Supplies industry. The net income increased by 274.1% when compared to the same quarter one year prior, rising from -$2.65 million to $4.62 million.
  • Current return on equity exceeded its ROE from the same quarter one year prior. This is a clear sign of strength within the company. When compared to other companies in the Health Care Equipment & Supplies industry and the overall market, ORASURE TECHNOLOGIES INC's return on equity is below that of both the industry average and the S&P 500.
  • OSUR is off 6.29% from its price level of one year ago, reflecting the general market trend and ignoring their higher earnings per share compared to the year-earlier quarter. The fact that the stock is now selling for less than others in its industry in relation to its current earnings is not reason enough to justify a buy rating at this time.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.